In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study

Aldo Badano; Andreu Badal; Stephen Glick; Christian G. Graff; Frank Samuelson; Diksha Sharma; Rongping Zeng

doi:10.1117/12.2255746

Translator Disclaimer

9 March 2017 In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study

Aldo Badano, Andreu Badal, Stephen Glick, Christian G. Graff, Frank Samuelson, Diksha Sharma, Rongping Zeng

Author Affiliations +

Proceedings Volume 10132, Medical Imaging 2017: Physics of Medical Imaging; 1013220 (2017) https://doi.org/10.1117/12.2255746
Event: SPIE Medical Imaging, 2017, Orlando, Florida, United States

Abstract

Expensive and lengthy clinical trials can delay regulatory evaluation and add significant burden that stifles innovation affecting patient access to novel, high-quality imaging technologies. In silico imaging holds promise for evaluating the safety and effectiveness of imaging technologies with much less burden than clinical trials. We define in silico imaging as a computer simulation of an entire imaging system (including source, object, task, and observer components) used for research, development, optimization, technology assessment, and regulatory evaluation of new technology. In this work we describe VICTRE (our study of virtual imaging clinical trials for regulatory evaluation) and the considerations for building an entire imaging pipeline in silico including device (physics), patient (anatomy, disease), and image interpretation models for regulatory evaluation using open-source tools.

Conference Presentation

Citation Download Citation

Aldo Badano, Andreu Badal, Stephen Glick, Christian G. Graff, Frank Samuelson, Diksha Sharma, and Rongping Zeng "In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study", Proc. SPIE 10132, Medical Imaging 2017: Physics of Medical Imaging, 1013220 (9 March 2017); https://doi.org/10.1117/12.2255746

ACCESS THE FULL ARTICLE